This elevation in cytokine levels results in liver inflammation and activates pathways involving oncogenic transcription factors such as signal transducer and activator of transcription 3 (STAT3), thus amplifying the risk of developing HCC [72]. The gene discussed is STAT3; the disease is hepatocellular carcinoma.